Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Double-Blind Study of PASER® in the Management of Patients Experiencing an Acute Flare of Crohn's Disease

NCT00417690 is registered in ClinicalTrials.gov with Jacobus Pharmaceutical as lead sponsor.

NCT NCT00417690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00417690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Double-Blind Study of PASER® in the Management of Patients Experiencing an Acute Flare of Crohn's Disease
Lead sponsor
Jacobus Pharmaceutical
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2007
Completion date
October 31, 2008
Enrollment
54 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease